Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
Titel:
Metabolic tumor volume and sites of organ involvement predict outcome in NSCLC immune-checkpoint inhibitor therapy
Auteur:
Kifjak, Daria Hochmair, Maximilian Sobotka, Daniel Haug, Alexander R. Ambros, Raphael Prayer, Florian Heidinger, Benedikt H. Roehrich, Sebastian Milos, Ruxandra-Iulia Wadsak, Wolfgang Fuereder, Thorsten Krenbek, Dagmar Fazekas, Andreas Meilinger, Michael Mayerhoefer, Marius E. Langs, Georg Herold, Christian Prosch, Helmut Beer, Lucian